Progesterone Receptor (PR) Test | Lahalak Platform
A vital test to evaluate breast and uterine tumor sensitivity to hormones, determining response to hormonal therapy and providing key information on disease behavior.
Scientific name: Immunohistochemistry: Progesterone Receptor (PR)
This immunohormonal diagnostic package is designed to evaluate breast and female reproductive tract tumors. It primarily focuses on measuring progesterone receptor (PR) expression, a nuclear transcription factor expressed in progesterone-responsive cells. The package also assesses estrogen receptor (ER) and the cytogenetic marker Ki-67, and additio...
Service type
Laboratory test (Tissue)
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Examination of progesterone receptor (PR) expression in the tissue sample.
- Estrogen receptor (ER) expression testing for complete hormonal classification.
- Examination of the Ki-67 proliferation marker to assess tumor activity.
- Consult with a pathologist to interpret the overall results and determine the subtype and treatment recommendations.
- Personal support services from Halak.
Medical Service Information
Conditions & Notices
- It requires the presentation of a complete tissue block (paraffin block) from the tumor biopsy (breast, uterus, etc.).
- The need to include the initial histological diagnosis.
- There is no need to fast, as it is a test on a tissue sample.
- Expected duration: 5 to 10 working days.
Medical services you might also like
